|
TCRX | Tscan Therapeutics, Inc. |
|
|
TCRX | Tscan Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 3.34 |
| Leverage | 45.08% |
| Market Cap | $ 43.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -142.1m |
| Margin | -982.08% |
None